Coral Laboratories stock reports strong June revenue growth

Published on 10/05/2026 at 17:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Coral Laboratories stock was quoted at INR 569.00 on October 1, 2026, while Q1 FY27 revenue reached INR 29.62 crore. Net profit stood at INR 5.39 crore.

Coral, INE683E01017, Illustration mit AI erstellt.

Coral Laboratories stock (ISIN INE683E01017) was last quoted at INR 569.00 on the BSE on October 1, 2026, with a 0.17 percent gain. The latest company milestone is the September 29 annual meeting, where shareholders approved the audited financial statements and final dividend, as listed by Moneycontrol.

Q1 revenue reached INR 29.62 crore

Coral Laboratories reported June 2026 revenue of INR 29.62 crore, up 57.3 percent from the June 2025 quarter. The operating result was INR 4.82 crore, while the operating margin stood at 16.27 percent, according to StockFin.ai.

The same June 2026 data show net profit of INR 5.39 crore and earnings per share of INR 15.08. Revenue therefore expanded faster than operating profit, a combination that leaves margin stability as the key measure for the next reported period.

Profit growth supports the dividend

The June 2026 quarter followed revenue of INR 26.48 crore in March 2026, making the sequential increase 11.9 percent. Net profit rose from INR 5.22 crore to INR 5.39 crore over the same comparison, while the operating margin fell from 21.37 percent to 16.27 percent, according to StockFin.ai.

The board-related disclosure dated September 25, 2026, also covered approval of the FY26 cost audit report. ScanX News reported that the company proposed a final dividend of INR 2.00 per share for FY26, while FY26 income fell to INR 95.7968 crore from INR 124.1139 crore in FY25.

Stock remains below the yearly high

On the October 1, 2026 BSE session, the quoted range was INR 546.50 to INR 585.00 and volume was 871 shares. The 52-week range stood at INR 360.00 to INR 679.00, placing the latest quote 16.20 percent below the yearly high.

For investors, the central contrast is clear: June 2026 revenue growth was strong, but the FY26 comparison showed lower annual income and the latest operating margin was below the March 2026 level.